Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia

Clinical trial NCT00251368 · COMPLETED

Trial details

NCT number: NCT00251368
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myelocytic, Acute Acute Lymphocytic Leukemia

Start date: 1995-01-01
Primary completion: 2007-09-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.